Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Vita Coco Company, Inc.COCO · Entity 4155 | Chief Commercial Officer | August 15, 2026 | August 19, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Vita Coco Company, Inc.
Report date August 15, 2026 · Filed August 19, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 48,284 |
Reported balance
After 2026-08-15 transaction · row 1
1 source rowRow 1 · 2026-08-15 · Tax withholding · Disposed 10,801 · Balance 48,284 F1: The disposition reported on this Form 4 represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The disposition is mandated by the Issuer and does not represent a discretionary transaction by the Reporting Person. |
| Non-Qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.18 · Expires 2030-02-10 | Direct | 53,750 |
Reported balance
Holding disclosure · report date 2026-08-15 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 53,750 F2: The stock option is fully vested and currently exercisable. |
| Non-Qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.18 · Expires 2031-01-11 | Direct | 27,300 |
Reported balance
Holding disclosure · report date 2026-08-15 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 27,300 F2: The stock option is fully vested and currently exercisable. |
| Non-Qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $15.00 · Expires 2031-10-21 | Direct | 58,043 |
Reported balance
Holding disclosure · report date 2026-08-15 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 58,043 F3: The stock option vests in four equal annual installments beginning on November 27, 2022. |
| Non-Qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $15.36 · Expires 2032-08-15 | Direct | 42,980 |
Reported balance
Holding disclosure · report date 2026-08-15 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 42,980 F4: The stock option vests in three equal annual installments beginning on August 15, 2025. |
| Non-Qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $16.91 · Expires 2033-03-10 | Direct | 14,025 |
Reported balance
Holding disclosure · report date 2026-08-15 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 14,025 F5: The stock option is eligible to vest if certain performance conditions are met by the target date for the applicable performance condition(s) and expire if the performance conditions are not met by the final target date. The performance conditions applicable were timely satisfied, resulting in vesting of the option as to 14,025 shares on February 20, 2026. |
| Non-Qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $16.91 · Expires 2033-03-10 | Direct | 14,205 |
Reported balance
Holding disclosure · report date 2026-08-15 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 14,205 F6: The stock options vest in four annual equal installments beginning on March 10, 2024. |
| Non-Qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $26.18 · Expires 2034-03-04 | Direct | 8,746 |
Reported balance
Holding disclosure · report date 2026-08-15 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 8,746 F7: The stock option vests in four equal annual installments beginning on March 4, 2025. |
| Non-Qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $33.36 · Expires 2035-03-04 | Direct | 13,218 |
Reported balance
Holding disclosure · report date 2026-08-15 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 13,218 F8: The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The disposition reported on this Form 4 represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The disposition is mandated by the Issuer and does not represent a discretionary transaction by the Reporting Person.
F2: The stock option is fully vested and currently exercisable.
F3: The stock option vests in four equal annual installments beginning on November 27, 2022.
F4: The stock option vests in three equal annual installments beginning on August 15, 2025.
F5: The stock option is eligible to vest if certain performance conditions are met by the target date for the applicable performance condition(s) and expire if the performance conditions are not met by the final target date. The performance conditions applicable were timely satisfied, resulting in vesting of the option as to 14,025 shares on February 20, 2026.
F6: The stock options vest in four annual equal installments beginning on March 10, 2024.
F7: The stock option vests in four equal annual installments beginning on March 4, 2025.
F8: The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 18, 2024 Filed Jun 18, 2024 23:26 UTC | Vita Coco Company, Inc. COCO · Entity 4155 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 6,123 | $0.00 Strike: $10.18 | $0.00 |
DisclosureSEC source: 0001482981-24-000091 · edgardoc.xml · derivative · entry 9 van Es Charles · CIK 0001886344 · Chief Sales Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,047 Underlying: Common Stock · 6,123 shares Expires 2029-12-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The stock option is fully vested and currently exercisable. Read SEC document |
| June 18, 2024 Filed Jun 18, 2024 23:26 UTC | Vita Coco Company, Inc. COCO · Entity 4155 | SaleCommon Stock | 6,123 | $30.01 | $183,745.11 |
DisclosureSEC source: 0001482981-24-000091 · edgardoc.xml · nonDerivative · entry 6 van Es Charles · CIK 0001886344 · Chief Sales Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 97,668 F1 · kind: The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.08, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 18, 2024 Filed Jun 18, 2024 23:26 UTC | Vita Coco Company, Inc. COCO · Entity 4155 | Exercise / conversionCommon Stock | 6,123 | $10.18 | $62,319.89 |
DisclosureSEC source: 0001482981-24-000091 · edgardoc.xml · nonDerivative · entry 5 van Es Charles · CIK 0001886344 · Chief Sales Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 103,791 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 17, 2024 Filed Jun 18, 2024 23:26 UTC | Vita Coco Company, Inc. COCO · Entity 4155 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 6,700 | $0.00 Strike: $10.18 | $0.00 |
DisclosureSEC source: 0001482981-24-000091 · edgardoc.xml · derivative · entry 8 van Es Charles · CIK 0001886344 · Chief Sales Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,170 Underlying: Common Stock · 6,700 shares Expires 2029-12-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The stock option is fully vested and currently exercisable. Read SEC document |
| June 17, 2024 Filed Jun 18, 2024 23:26 UTC | Vita Coco Company, Inc. COCO · Entity 4155 | SaleCommon Stock | 6,700 | $30.04 | $201,268.00 |
DisclosureSEC source: 0001482981-24-000091 · edgardoc.xml · nonDerivative · entry 4 van Es Charles · CIK 0001886344 · Chief Sales Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 97,668 F1 · kind: The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.28, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 17, 2024 Filed Jun 18, 2024 23:26 UTC | Vita Coco Company, Inc. COCO · Entity 4155 | Exercise / conversionCommon Stock | 6,700 | $10.18 | $68,192.60 |
DisclosureSEC source: 0001482981-24-000091 · edgardoc.xml · nonDerivative · entry 3 van Es Charles · CIK 0001886344 · Chief Sales Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 104,368 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 14, 2024 Filed Jun 18, 2024 23:26 UTC | Vita Coco Company, Inc. COCO · Entity 4155 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 2,805 | $0.00 Strike: $10.18 | $0.00 |
DisclosureSEC source: 0001482981-24-000091 · edgardoc.xml · derivative · entry 7 van Es Charles · CIK 0001886344 · Chief Sales Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,870 Underlying: Common Stock · 2,805 shares Expires 2029-12-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The stock option is fully vested and currently exercisable. Read SEC document |
| June 14, 2024 Filed Jun 18, 2024 23:26 UTC | Vita Coco Company, Inc. COCO · Entity 4155 | SaleCommon Stock | 2,805 | $30.06 | $84,318.30 |
DisclosureSEC source: 0001482981-24-000091 · edgardoc.xml · nonDerivative · entry 2 van Es Charles · CIK 0001886344 · Chief Sales Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 97,668 F1 · kind: The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.34, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 14, 2024 Filed Jun 18, 2024 23:26 UTC | Vita Coco Company, Inc. COCO · Entity 4155 | Exercise / conversionCommon Stock | 2,805 | $10.18 | $28,549.29 |
DisclosureSEC source: 0001482981-24-000091 · edgardoc.xml · nonDerivative · entry 1 van Es Charles · CIK 0001886344 · Chief Sales Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 100,473 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 14, 2024 Filed Mar 15, 2024 20:54 UTC | Vita Coco Company, Inc. COCO · Entity 4155 | SaleCommon Stock | 595 | $25.19 | $14,988.05 |
DisclosureSEC source: 0001482981-24-000042 · edgardoc.xml · nonDerivative · entry 1 van Es Charles · CIK 0001886344 · Chief Sales Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,668 F1 · kind: The sales reported represent shares automatically sold in a non-discretionary transaction to cover taxes and fees in connection with the vesting of restricted stock units previously granted to the reporting person. Read SEC document |
| March 04, 2024 Filed Mar 7, 2024 00:39 UTC | Vita Coco Company, Inc. COCO · Entity 4155 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 8,746 | $0.00 Strike: $26.18 | $0.00 |
DisclosureSEC source: 0001482981-24-000028 · edgardoc.xml · derivative · entry 2 van Es Charles · CIK 0001886344 · Chief Sales Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,746 Underlying: Common Stock · 8,746 shares Expires 2034-03-04 F2 · derivative.exercise_date: The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date. Read SEC document |
| March 04, 2024 Filed Mar 7, 2024 00:39 UTC | Vita Coco Company, Inc. COCO · Entity 4155 | GrantCommon Stock | 10,542 | $0.00 | $0.00 |
DisclosureSEC source: 0001482981-24-000028 · edgardoc.xml · nonDerivative · entry 1 van Es Charles · CIK 0001886344 · Chief Sales Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 98,263 F1 · kind: The Reporting Person was granted restricted stock units that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date. Unless otherwise provided, on each vesting date shares of Common Stock will automatically be sold to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction. Read SEC document |
| November 29, 2023 Filed Dec 1, 2023 21:46 UTC | Vita Coco Company, Inc. COCO · Entity 4155 | SaleCommon Stock | 5,537 | $28.84 | $159,687.08 |
DisclosureSEC source: 0001482981-23-000122 · edgardoc.xml · nonDerivative · entry 1 van Es Charles · CIK 0001886344 · Chief Sales Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,721 F1 · kind: The sales reported represent shares automatically sold in a non-discretionary transaction to cover taxes and fees in connection with the vesting of restricted stock units previously granted to the reporting person. Read SEC document |
| November 01, 2023 Filed Nov 3, 2023 22:22 UTC | Vita Coco Company, Inc. COCO · Entity 4155 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 28,200 | $0.00 Strike: $10.18 | $0.00 |
DisclosureSEC source: 0001482981-23-000110 · edgardoc.xml · derivative · entry 3 van Es Charles · CIK 0001886344 · Chief Sales Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 39,675 Underlying: Common Stock · 28,200 shares Expires 2029-12-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock option is fully vested and currently exercisable. Read SEC document |
| November 01, 2023 Filed Nov 3, 2023 22:22 UTC | Vita Coco Company, Inc. COCO · Entity 4155 | SaleCommon Stock | 28,200 | $28.14 | $793,407.00 |
DisclosureSEC source: 0001482981-23-000110 · edgardoc.xml · nonDerivative · entry 2 van Es Charles · CIK 0001886344 · Chief Sales Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 93,258 F1 · kind: The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.00 to $28.34, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 01, 2023 Filed Nov 3, 2023 22:22 UTC | Vita Coco Company, Inc. COCO · Entity 4155 | Exercise / conversionCommon Stock | 28,200 | $10.18 | $287,019.60 |
DisclosureSEC source: 0001482981-23-000110 · edgardoc.xml · nonDerivative · entry 1 van Es Charles · CIK 0001886344 · Chief Sales Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 121,458 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2023 Filed Sep 18, 2023 22:51 UTC | Vita Coco Company, Inc. COCO · Entity 4155 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 1,800 | $0.00 Strike: $10.18 | $0.00 |
DisclosureSEC source: 0001482981-23-000095 · edgardoc.xml · derivative · entry 12 van Es Charles · CIK 0001886344 · Chief Sales Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 67,875 Underlying: Common Stock · 1,800 shares Expires 2029-12-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock option is fully vested and currently exercisable. Read SEC document |
| September 15, 2023 Filed Sep 18, 2023 22:51 UTC | Vita Coco Company, Inc. COCO · Entity 4155 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 14,685 | $0.00 Strike: $10.18 | $0.00 |
DisclosureSEC source: 0001482981-23-000095 · edgardoc.xml · derivative · entry 11 van Es Charles · CIK 0001886344 · Chief Sales Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 69,675 Underlying: Common Stock · 14,685 shares Expires 2029-12-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock option is fully vested and currently exercisable. Read SEC document |
| September 15, 2023 Filed Sep 18, 2023 22:51 UTC | Vita Coco Company, Inc. COCO · Entity 4155 | SaleCommon Stock | 1,800 | $28.70 | $51,658.20 |
DisclosureSEC source: 0001482981-23-000095 · edgardoc.xml · nonDerivative · entry 8 van Es Charles · CIK 0001886344 · Chief Sales Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 93,258 F1 · kind: The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.95 to $29.06, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| September 15, 2023 Filed Sep 18, 2023 22:51 UTC | Vita Coco Company, Inc. COCO · Entity 4155 | Exercise / conversionCommon Stock | 1,800 | $10.18 | $18,320.40 |
DisclosureSEC source: 0001482981-23-000095 · edgardoc.xml · nonDerivative · entry 7 van Es Charles · CIK 0001886344 · Chief Sales Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 95,058 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2023 Filed Sep 18, 2023 22:51 UTC | Vita Coco Company, Inc. COCO · Entity 4155 | SaleCommon Stock | 14,685 | $26.87 | $394,585.95 |
DisclosureSEC source: 0001482981-23-000095 · edgardoc.xml · nonDerivative · entry 6 van Es Charles · CIK 0001886344 · Chief Sales Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 93,258 F1 · kind: The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.95 to $29.06, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| September 15, 2023 Filed Sep 18, 2023 22:51 UTC | Vita Coco Company, Inc. COCO · Entity 4155 | Exercise / conversionCommon Stock | 14,685 | $10.18 | $149,463.93 |
DisclosureSEC source: 0001482981-23-000095 · edgardoc.xml · nonDerivative · entry 5 van Es Charles · CIK 0001886344 · Chief Sales Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 107,943 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 14, 2023 Filed Sep 18, 2023 22:51 UTC | Vita Coco Company, Inc. COCO · Entity 4155 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 15,315 | $0.00 Strike: $10.18 | $0.00 |
DisclosureSEC source: 0001482981-23-000095 · edgardoc.xml · derivative · entry 10 van Es Charles · CIK 0001886344 · Chief Sales Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 84,360 Underlying: Common Stock · 15,315 shares Expires 2029-12-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock option is fully vested and currently exercisable. Read SEC document |
| September 14, 2023 Filed Sep 18, 2023 22:51 UTC | Vita Coco Company, Inc. COCO · Entity 4155 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $10.18 | $0.00 |
DisclosureSEC source: 0001482981-23-000095 · edgardoc.xml · derivative · entry 9 van Es Charles · CIK 0001886344 · Chief Sales Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 99,675 Underlying: Common Stock · 30,000 shares Expires 2029-12-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock option is fully vested and currently exercisable. Read SEC document |
| September 14, 2023 Filed Sep 18, 2023 22:51 UTC | Vita Coco Company, Inc. COCO · Entity 4155 | SaleCommon Stock | 15,315 | $29.59 | $453,155.54 |
DisclosureSEC source: 0001482981-23-000095 · edgardoc.xml · nonDerivative · entry 4 van Es Charles · CIK 0001886344 · Chief Sales Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 93,258 F1 · kind: The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.44 to $31.90, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| September 14, 2023 Filed Sep 18, 2023 22:51 UTC | Vita Coco Company, Inc. COCO · Entity 4155 | Exercise / conversionCommon Stock | 15,315 | $10.18 | $155,876.07 |
DisclosureSEC source: 0001482981-23-000095 · edgardoc.xml · nonDerivative · entry 3 van Es Charles · CIK 0001886344 · Chief Sales Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 108,573 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 14, 2023 Filed Sep 18, 2023 22:51 UTC | Vita Coco Company, Inc. COCO · Entity 4155 | SaleCommon Stock | 30,000 | $29.59 | $887,670.00 |
DisclosureSEC source: 0001482981-23-000095 · edgardoc.xml · nonDerivative · entry 2 van Es Charles · CIK 0001886344 · Chief Sales Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 93,258 F1 · kind: The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.44 to $31.90, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| September 14, 2023 Filed Sep 18, 2023 22:51 UTC | Vita Coco Company, Inc. COCO · Entity 4155 | Exercise / conversionCommon Stock | 30,000 | $10.18 | $305,340.00 |
DisclosureSEC source: 0001482981-23-000095 · edgardoc.xml · nonDerivative · entry 1 van Es Charles · CIK 0001886344 · Chief Sales Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 123,258 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 10, 2023 Filed Mar 15, 2023 01:36 UTC | Vita Coco Company, Inc. COCO · Entity 4155 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 14,205 | $0.00 Strike: $16.91 | $0.00 |
DisclosureSEC source: 0001482981-23-000034 · edgardoc.xml · derivative · entry 2 van Es Charles · CIK 0001886344 · Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,205 Underlying: Common Stock · 14,205 shares Expires 2033-03-10 F2 · derivative.exercise_date: The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date. Read SEC document |
| March 10, 2023 Filed Mar 15, 2023 01:36 UTC | Vita Coco Company, Inc. COCO · Entity 4155 | GrantCommon Stock | 5,914 | $0.00 | $0.00 |
DisclosureSEC source: 0001482981-23-000034 · edgardoc.xml · nonDerivative · entry 1 van Es Charles · CIK 0001886344 · Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,258 F1 · kind: The Reporting Person was granted restricted stock units that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date. Unless otherwise provided, on each vesting date shares of Common Stock will automatically be sold to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction. Read SEC document |
| December 01, 2022 Filed Dec 1, 2022 22:00 UTC | Vita Coco Company, Inc. COCO · Entity 4155 | SaleCommon Stock | 5,721 | $12.34 | $70,591.42 |
DisclosureSEC source: 0001482981-22-000084 · edgardoc.xml · nonDerivative · entry 2 van Es Charles · CIK 0001886344 · Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,344 F2 · kind: The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.12 to $12.42, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F4 · balance_after: These shares consist of unvested restricted stock units. The reporting person initially reported the restricted stock units relating to this vesting in Table II of Form 4. The total reported in Column 5 reflects 38,333 restricted stock units previously reported in Table II minus those shares that were sold as indicated on this Form 4. Read SEC document |
| November 29, 2022 Filed Dec 1, 2022 22:00 UTC | Vita Coco Company, Inc. COCO · Entity 4155 | SaleCommon Stock | 3,862 | $11.29 | $43,599.28 |
DisclosureSEC source: 0001482981-22-000084 · edgardoc.xml · nonDerivative · entry 1 van Es Charles · CIK 0001886344 · Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,065 F1 · kind: The sales reported represent shares automatically sold in a non-discretionary transaction to cover taxes and fees in connection with the vesting of restricted stock units previously granted to the reporting person. Read SEC document |
| August 15, 2022 Filed Aug 17, 2022 21:39 UTC | Vita Coco Company, Inc. COCO · Entity 4155 | GrantStock Option (Right to Buy) · Derivative | 42,980 | $0.00 Strike: $15.36 | $0.00 |
DisclosureSEC source: 0001886344-22-000002 · wf-form4_166077235029063.xml · derivative · entry 2 van Es Charles · CIK 0001886344 · Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,980 Underlying: Common Stock · 42,980 shares Expires 2032-08-15 F3 · derivative.exercise_date: The Reporting Person was granted stock options that will vest in three equal annual installments beginning on August 15, 2025. Read SEC document |
| August 15, 2022 Filed Aug 17, 2022 21:39 UTC | Vita Coco Company, Inc. COCO · Entity 4155 | GrantCommon Stock | 58,594 | $0.00 | $0.00 |
DisclosureSEC source: 0001886344-22-000002 · wf-form4_166077235029063.xml · nonDerivative · entry 1 van Es Charles · CIK 0001886344 · Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,927 F1 · shares: The Reporting Person was granted restricted stock units that will vest in three equal annual installments beginning on August 15, 2025. F2 · balance_after: These shares consist of unvested restricted stock units. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 23:58 UTC | Vita Coco Company, Inc. COCO · Entity 4155 | GrantStock Option (Right to Buy) · Derivative | 9,100 | $0.00 Strike: $10.18 | $0.00 |
DisclosureSEC source: 0000899243-22-006671 · doc4.xml · derivative · entry 1 van Es Charles · CIK 0001886344 · Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,100 Underlying: Common Stock · 9,100 shares Expires 2031-01-11 F1 · derivative.exercise_date: On January 11, 2021, the Reporting Person was granted an option to purchase 18,200 shares of common stock that vest upon the achievement of certain performance criteria. Certain of the performance criteria for 2021 were met, and as such, 9,100 options will vest in two equal installments on and after January 11, 2023 and January 11, 2025. Read SEC document |
| October 21, 2021 Filed Oct 25, 2021 20:57 UTC | Vita Coco Company, Inc. COCO · Entity 4155 | GrantRestricted Stock Units · Derivative | 38,333 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-041458 · doc4.xml · derivative · entry 1 van Es Charles · CIK 0001886344 · Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,333 Underlying: Common Stock · 38,333 shares Expires not disclosed F1 · derivative.exercise_price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs will vest in four annual equal installments starting November 27, 2022 provided that the Reporting Person remains in continuous service on each vesting date. Unless otherwise provided, on each vesting date shares of Common Stock will automatically be sold to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction. F1 · derivative.exercise_date: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs will vest in four annual equal installments starting November 27, 2022 provided that the Reporting Person remains in continuous service on each vesting date. Unless otherwise provided, on each vesting date shares of Common Stock will automatically be sold to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction. F1 · derivative.expiration_date: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs will vest in four annual equal installments starting November 27, 2022 provided that the Reporting Person remains in continuous service on each vesting date. Unless otherwise provided, on each vesting date shares of Common Stock will automatically be sold to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.